Literature DB >> 7053899

Right ventricular dysplasia: a report of 24 adult cases.

F I Marcus, G H Fontaine, G Guiraudon, R Frank, J L Laurenceau, C Malergue, Y Grosgogeat.   

Abstract

Right ventricular dysplasia is characterized by an abnormality in the development of part of the right ventricular musculature. Patients with right ventricular dysplasia may present with ventricular tachycardia, supraventricular arrhythmias, right-heart failure or asymptomatic cardiomegaly. Twenty-two adult patients with right ventricular dysplasia who had recurrent ventricular tachycardia were seen during a 7-year period. The male/female ratio was 2.7:1. The mean age at the time of hospitalization was 39 years. All but one of the patients had ventricular tachycardia of a left bundle branch block configuration. With few exceptions, the T waves were inverted over the right precordial leads. The heart was usually enlarged and the pulmonary vasculature was usually normal. In six patients who had two-dimensional echocardiograms, all showed increased right ventricular diastolic dimensions. All patients had right ventricular angiography; the diagnosis of right ventricular dysplasia was substantiated during surgery in 12 patients and at autopsy in another. Two other patients who did not have arrhythmias had right ventricular dysplasia diagnosed by right- and left-heart angiography. Our unique experience, when combined with a literature review of 34 adult cases, permits a composite clinical profile of this condition in the adult.

Entities:  

Mesh:

Year:  1982        PMID: 7053899     DOI: 10.1161/01.cir.65.2.384

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  274 in total

Review 1.  Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment.

Authors:  D Corrado; C Basso; G Thiene
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

2.  Arrhythmogenic right ventricular dysplasia. An illustrated review highlighting developments in the diagnosis and management of this potentially fatal condition.

Authors:  N G Fisher; T J Gilbert
Journal:  Postgrad Med J       Date:  2000-07       Impact factor: 2.401

Review 3.  Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).

Authors:  Jorge Romero; Michael Grushko; David F Briceño; Andrea Natale; Luigi Di Biase
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

4.  Symptomatic Ventricular Tachycardia.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-08

5.  Magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular cardiomyopathy: the gold standard or just another imaging modality?

Authors:  Irene Stevenson; Jonathan Kalman
Journal:  J Interv Card Electrophysiol       Date:  2004-02       Impact factor: 1.900

6.  The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14.

Authors:  D Li; F Ahmad; M J Gardner; D Weilbaecher; R Hill; A Karibe; O Gonzalez; T Tapscott; G P Sharratt; L L Bachinski; R Roberts
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

7.  Right atrial pathology in arrhythmogenic right ventricular dysplasia.

Authors:  Guoliang Li; Guy H Fontaine; Shuanliang Fan; Yang Yan; Peter K Bode; Firat Duru; Robert Frank; Ardan M Saguner
Journal:  Cardiol J       Date:  2018-11-05       Impact factor: 2.737

Review 8.  Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease.

Authors:  Ardan M Saguner; Corinna Brunckhorst; Firat Duru
Journal:  World J Cardiol       Date:  2014-04-26

9.  Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre.

Authors:  K Lemola; C Brunckhorst; U Helfenstein; E Oechslin; R Jenni; F Duru
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

Review 10.  [Right ventricular arrhythmias].

Authors:  T Wichter; M Paul; L Eckardt; G Breithardt
Journal:  Internist (Berl)       Date:  2004-10       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.